Login / Signup

Exploring the therapeutic potential of prolinamides as multi-targeted agents for Alzheimer's disease treatment: molecular docking and molecular dynamic simulation studies.

Samuel O OlalekanVincent A ObakachiAbosede A BadejiOyesolape B Akinsipo OyelajaOluwole FamiloniOlayinka T AsekunSegun D OladipoAdejoke D Osinubi
Published in: In silico pharmacology (2024)
The online version contains supplementary material available at 10.1007/s40203-024-00250-z.
Keyphrases
  • molecular docking
  • molecular dynamics simulations
  • cognitive decline
  • health information
  • psychometric properties
  • case control
  • combination therapy
  • virtual reality
  • drug delivery
  • replacement therapy
  • smoking cessation